Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unleashing inkjet-printed nanostructured electrodes and battery-free potentiostat for the DNA-based multiplexed detection of SARS-CoV-2 genes

  • Rossetti, Marianna
  • Srisomwat, Chawin
  • Urban, Massimo
  • Rosati, Giulio
  • Maroli, Gabriel
  • Yaman Akbay, Hatice Gödze
  • Chailapakul, Orawon
  • Merkoçi, Arben
Following the global COVID-19 pandemic triggered by SARS-CoV-2, the need for rapid, specific and cost-effective point-of-care diagnostic solutions remains paramount. Even though COVID-19 is no longer a public health emergency, the disease still poses a global threat leading to deaths, and it continues to change with the risk of new variants emerging causing a new surge in cases and deaths. Here, we address the urgent need for rapid, cost-effective and point-of-care diagnostic solutions for SARS-CoV-2. We propose a multiplexed DNA-based sensing platform that utilizes inkjet-printed nanostructured gold electrodes and an inkjet-printed battery-free near-field communication (NFC) potentiostat for the simultaneous quantitative detection of two SARS-CoV-2 genes, the ORF1ab and the N gene. The detection strategy based on the formation of an RNA-DNA sandwich structure leads to a highly specific electrochemical output. The inkjet-printed nanostructured gold electrodes providing a large surface area enable efficient binding and increase the sensitivity. The inkjet-printed battery-free NFC potentiostat enables rapid measurements and real-time data analysis via a smartphone application, making the platform accessible and portable. With the advantages of speed (5 min), simplicity, sensitivity (low pM range, ∼450% signal gain) and cost-effectiveness, the proposed platform is a promising alternative for point-of-care diagnostics and high-throughput analysis that complements the COVID-19 diagnostic toolkit., ICN2 is funded by CERCA programme, Generalitat de Catalunya. Grant SEV-2017-0706 funded by MCIN/AEI/10.13039/501100011033. This project was in part supported from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101008701 (Project EMERGE), from PID2021-124795NB-I00 funded by MCIN/AEI/10.13039/501100011033 and from “ERDF A way of making Europe”. M.R. is supported from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 101029884 (SERENA). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. The European Union can not be held responsible for them. M.U. has carried out the work within the framework of the doctoral program ‘Doctorado en Biotecnología’ from the Universitat Autònoma de Barcelona. G.M. would like to express his gratitude to the Carolina Foundation for financial support through the scholarship “Doctorado 2020.” G.M. acknowledges Universitat Autonoma de Barcelona (UAB) for the possibility of performing this work inside the framework of Chemistry PhD Programme. C.S. and O.C. would like to thank the National Research Council of Thailand (NRCT) through the Royal Golden Jubilee Ph.D. program (grant number PHD/0016/2561) and the Distinguished Research Professor Grant, the National Research Council of Thailand (NRCT) through the grant number N41A640073., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Harnessing bioluminescent bacteria to develop an enzymatic-free enzyme-linked immunosorbent assay for the detection of clinically relevant biomarkers

  • Hu, Liming
  • Rossetti, Marianna
  • Bergua, José Francisco
  • Parolo, Claudio
  • Álvarez-Diduk, Ruslan
  • Rivas, Lourdes
  • Idili, Andrea
  • Merkoçi, Arben
Enzyme-linked immunosorbent assay (ELISA) is the gold standard technique for measuring protein biomarkers due to its high sensitivity, specificity, and throughput. Despite its success, continuous advancements in ELISA and immunoassay formats are crucial to meet evolving global challenges and to address new analytical needs in diverse applications. To expand the capabilities and applications of immunoassays, we introduce a novel ELISA-like assay that we call Bioluminescent-bacteria-linked immunosorbent assay (BBLISA). BBLISA is an enzyme-free assay that utilizes the inner filter effect between the bioluminescent bacteriaAllivibrio fischeriand metallic nanoparticles (gold nanoparticles and gold iridium oxide nanoflowers) as molecular absorbers. Functionalizing these nanoparticles with antibodies induces their accumulation in wells upon binding to molecular targets, forming the classical immune-sandwich complex. Thanks to their ability to adsorb the light emitted by the bacteria, the nanoparticles can suppress the bioluminescence signal, allowing the rapid quantification of the target. To demonstrate the bioanalytical properties of the novel immunoassay platform, as a proof of principle, we detected two clinically relevant biomarkers (human immunoglobulin G and SARS-CoV-2 nucleoprotein) in human serum, achieving the same sensitivity and precision as the classic ELISA. We believe that BBLISA can be a promising alternative to the standard ELISA techniques, offering potential advancements in biomarker detection and analysis by combining nanomaterials with a low-cost, portable bioluminescent platform., We acknowledge Consejo Superior de Investigaciones Científicas (CSIC) for the project “COVID19-122”. TheMICROB-PREDICT project has received funding from theEuropean Union’s Horizon 2020 research and innovationprogramme under grant agreement no 881603. ICN2 is fundedby CERCA programme / Generalitat de Catalunya, and issupported by the Severo Ochoa Centres of Excellenceprogramme, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. L.H. acknowledges ChinaScholarship Council (no. 201808360196) and acknowledges Universitat Autonoma de Barcelona (UAB) for the possibilityof performing this work inside the framework of Biotechnology Ph.D. Programme. M.R. acknowledges the MSCA projectfunded the European Union’s Horizon 2020 research andinnovation programme under the Marie Sklodowska-Curiegrant agreement no 101029884. C.P. acknowledges supportfrom the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, support from the Generalitat deCatalunya through the CERCA Program and support from theSpanish Ministry of Science and Innovation through theprogram PID2020-116770RJ-I00 and CPP2021-008658. TheICN2 is funded by the CERCA programme / Generalitat deCatalunya. The ICN2 is A.M. acknowledge Departament deRecerca i Universitats of Generalitat de Catalunya for the grant 2021 SGR 01464. This project has received funding from the European Union’s Horizon Europe − the Framework Programme for Research and Innovation (2021-2027) undergrant agreement No 101120706., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001214-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2018-000806-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Low-cost inkjet-printed nanostructured biosensor based on CRISPR/Cas12a system for pathogen detection

  • Carota, Angela Gilda
  • Bonini, Andrea
  • Urban, Massimo
  • Poma, Noemi
  • Vivaldi, Federico M.
  • Tavanti, Arianna
  • Rossetti, Marianna
  • Rosati, Giulio
  • Merkoçi, Arben
  • Di Francesco, Fabio
The escalating global incidence of infectious diseases caused by pathogenic bacteria, especially in developing countries, emphasises the urgent need for rapid and portable pathogen detection devices. This study introduces a sensitive and specific electrochemical biosensing platform utilising cost-effective electrodes fabricated by inkjet-printing gold and silver nanoparticles on a plastic substrate. The biosensor exploits the CRISPR/Cas12a system for detecting a specific DNA sequence selected from the genome of the target pathogen. Upon detection, the trans-activity of Cas12a/gRNA is triggered, leading to the cleavage of rationally designed single-strand DNA reporters (linear and hairpin) labelled with methylene blue (ssDNA-MB) and bound to the electrode surface. In principle, this sensing mechanism can be adapted to any bacterium by choosing a proper guide RNA to target a specific sequence of its DNA. The biosensor's performance was assessed for two representative pathogens (a Gram-negative, Escherichia coli, and a Gram-positive, Staphylococcus aureus), and results obtained with inkjet-printed gold electrodes were compared with those obtained by commercial screen-printed gold electrodes. Our results show that the use of inkjet-printed nanostructured gold electrodes, which provide a large surface area, in combination with the use of hairpin reporters containing a poly-T loop can increase the sensitivity of the assay corresponding to a signal variation of 86%. DNA targets amplified from various clinically isolated bacteria, have been tested and demonstrate the potential of the proposed platform for point-of-need applications., A.G.C. acknowledges the University of Pisa and the doctoral scholarship in memory of Giulio Regeni. A.B. was supported by the project CRISPRSENSE funded by Tuscany region, Italy (“DECRT. DIRIG. n. 21607 of 29-11-2021”). F.D.F. acknowledges the INSTM three-year project 2021-2024 “Sviluppo di sensori per la misura dell'attività proteasica e l'identificazione di batteri”. The work at ICN2 and the fabrication of the devices was partially funded by project EMERGE. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101008701. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. The European Union can not be held responsible for them. The development of the device fabrication platforms has been partially funded through the MICROB-PREDICT project. The MICROB-PREDICT project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825694. This reflects only the author's view, and the European Commission is not responsible for any use that may be made of the information it contains. The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, Grant CEX 2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. M.R. is supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 101029884 (SERENA). We acknowledge Departament de Recerca i Universitats of Generalitat de Catalunya for the grant 2021 SGR 01464., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001214-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reduced graphene oxide electrodes meet lateral flow assays: A promising path to advanced point-of-care diagnostics

  • Calucho, Enric
  • Álvarez-Diduk, Ruslan
  • Piper, Andrew
  • Rossetti, Marianna
  • Nevanen, Tarja K.
  • Merkoçi, Arben
Research in electrochemical detection in lateral flow assays (LFAs) has gained significant momentum in recent years. The primary impetus for this surge in interest is the pursuit of achieving lower limits of detection, especially given that LFAs are the most widely employed point-of-care biosensors. Conventionally, the strategy for merging electrochemistry and LFAs has centered on the superposition of screen-printed electrodes onto nitrocellulose substrates during LFA fabrication. Nevertheless, this approach poses substantial limitations regarding scalability. In response, we have developed a novel method for the complete integration of reduced graphene oxide (rGO) electrodes into LFA strips. We employed a CO2 laser to concurrently reduce graphene oxide and pattern nitrocellulose, exposing its backing to create connection sites impervious to sample leakage. Subsequently, rGO and nitrocellulose were juxtaposed and introduced into a roll-to-roll system using a wax printer. The exerted pressure facilitated the transfer of rGO onto the nitrocellulose. We systematically evaluated several electrochemical strategies to harness the synergy between rGO and LFAs. While certain challenges persist, our rGO transfer technology presents compelling potential for setting a new standard in electrochemical LFA fabrication., This work has received funding from the European Union’s Horizon 2020 research and innovation programme under the Graphene Flagship grant agreement no. 881603. The support received is also acknowledged by R. Alvarez. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. The European Union cannot be held responsible for them. This project has received funding from the European Union’s Horizon Europe – the Framework Programme for Research and Innovation (2021–2027) under grant agreement No 101120706. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. E. Calucho acknowledges Ministerio de Ciencia e Innovación of Spain and Fondo Social Europeo for the Fellowship PRE2018-084856 awarded under the call “Ayudas para contratos predoctorales para la formación de doctors, Subprograma Estatal de Formación del Programa Estatal de Promoción del Talento y su Empleabilidad en I + D + i”, under the framework of “Plan Estatal de Investigación Científica y Técnica y de Innovación 2017–2020”. E. Calucho also acknowledges Universitat Autònoma de Barcelona (UAB) for the possibility of performing this work inside the framework of Biotechnology PhD Programme. M. Rossetti is supported from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101029884 (SERENA). We acknowledge Departament de Recerca i Universitats of Generalitat de Catalunya for the grant 2021 SGR 01464 and Grant PID2021-124795NB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe”., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A paper-based fluorescent biosensing platform for miRNA detection with dual high-throughput and smartphone readout

  • Rossetti, Marianna
  • Álvarez-Diduk, Ruslan
  • Hu, Liming
  • Capolungo, Chiara
  • Maroli, Gabriel
  • Calucho, Enric
  • Merkoçi, Arben
The detection of oligonucleotide biomarkers in biological fluids is central to modern diagnostics, particularly for minimally invasive liquid biopsy approaches. Among these, microRNAs (miRNAs) are highly informative due to their regulatory roles in gene expression and their remarkable stability in body fluids. However, established miRNA detection methods such as qRT-PCR and microarrays require complex, multi-step workflows, expensive instrumentation, and specialised laboratory infrastructure, limiting their use in point-of-care settings. Here, we present a flexible, dry-reagent paper-based biosensing platform for rapid and quantitative miRNA detection, based on fluorescent molecular beacon (MB)-functionalised gold nanoparticles (AuNPs) embedded within nitrocellulose membranes. Target-induced hybridisation of miRNAs to the MB probes generates a fluorescence signal that can be quantified using either a conventional microplate reader for high-throughput analysis or a fully portable, low-cost smartphone-based optical reader with LED excitation. The assay enables robust detection in the low-nanomolar concentration range directly on paper substrates, with improved apparent affinity compared to solution-based measurements. Although the current sensitivity does not yet reach the levels required for direct, amplification-free analysis of miRNAs in clinical liquid biopsies, the platform provides a scalable and versatile foundation compatible with upstream amplification strategies and decentralised testing workflows. Overall, this work establishes a user-friendly and adaptable diagnostic architecture with strong potential for translation into point-of-care nucleic acid testing in both clinical and resource-limited environments., We acknowledge Fundació The Barcelona Institute of Science and Tecnhology (BIST) for the MAKI-2 project granted through the program BIST IGNITE. M.R. was supported from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101029884 (SERENA). L.H. acknowledges China Scholarship Council (No. 201808360196). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Harnessing Bioluminescent Bacteria to Develop an Enzymatic-free Enzyme-linked immunosorbent assay for the Detection of Clinically Relevant Biomarkers

  • Hu, Liming|||0000-0002-8666-9287
  • Rossetti, Marianna|||0000-0001-5711-1287
  • Bergua Canudo, José Francisco|||0000-0002-5969-193X
  • Parolo, Claudio|||0000-0001-9481-4408
  • Álvarez Diduk, Ruslan|||0000-0002-9876-1574
  • Rivas, Lourdes|||0000-0002-1510-5927
  • Idili, Andrea|||0000-0002-6004-270X
  • Merkoçi, Arben|||0000-0003-2486-8085
Enzyme-linked immunosorbent assay (ELISA) is the gold standard technique for measuring protein biomarkers due to its high sensitivity, specificity, and throughput. Despite its success, continuous advancements in ELISA and immunoassay formats are crucial to meet evolving global challenges and to address new analytical needs in diverse applications. To expand the capabilities and applications of immunoassays, we introduce a novel ELISA-like assay that we call Bioluminescent-bacteria-linked immunosorbent assay (BBLISA). BBLISA is an enzyme-free assay that utilizes the inner filter effect between the bioluminescent bacteriaAllivibrio fischeriand metallic nanoparticles (gold nanoparticles and gold iridium oxide nanoflowers) as molecular absorbers. Functionalizing these nanoparticles with antibodies induces their accumulation in wells upon binding to molecular targets, forming the classical immune-sandwich complex. Thanks to their ability to adsorb the light emitted by the bacteria, the nanoparticles can suppress the bioluminescence signal, allowing the rapid quantification of the target. To demonstrate the bioanalytical properties of the novel immunoassay platform, as a proof of principle, we detected two clinically relevant biomarkers (human immunoglobulin G and SARS-CoV-2 nucleoprotein) in human serum, achieving the same sensitivity and precision as the classic ELISA. We believe that BBLISA can be a promising alternative to the standard ELISA techniques, offering potential advancements in biomarker detection and analysis by combining nanomaterials with a low-cost, portable bioluminescent platform.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reduced graphene oxide electrodes meet lateral flow assays, A promising path to advanced point-of-care diagnostics

  • Calucho, Enric|||0000-0002-6024-765X
  • Álvarez Diduk, Ruslan|||0000-0002-9876-1574
  • Piper, Andrew|||0000-0002-1208-8009
  • Rossetti, Marianna|||0000-0001-5711-1287
  • Nevanen, Tarja K.
  • Merkoçi, Arben|||0000-0003-2486-8085
Research in electrochemical detection in lateral flow assays (LFAs) has gained significant momentum in recent years. The primary impetus for this surge in interest is the pursuit of achieving lower limits of detection, especially given that LFAs are the most widely employed point-of-care biosensors. Conventionally, the strategy for merging electrochemistry and LFAs has centered on the superposition of screen-printed electrodes onto nitrocellulose substrates during LFA fabrication. Nevertheless, this approach poses substantial limitations regarding scalability. In response, we have developed a novel method for the complete integration of reduced graphene oxide (rGO) electrodes into LFA strips. We employed a CO laser to concurrently reduce graphene oxide and pattern nitrocellulose, exposing its backing to create connection sites impervious to sample leakage. Subsequently, rGO and nitrocellulose were juxtaposed and introduced into a roll-to-roll system using a wax printer. The exerted pressure facilitated the transfer of rGO onto the nitrocellulose. We systematically evaluated several electrochemical strategies to harness the synergy between rGO and LFAs. While certain challenges persist, our rGO transfer technology presents compelling potential for setting a new standard in electrochemical LFA fabrication.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Low-cost inkjet-printed nanostructured biosensor based on CRISPR/Cas12a system for pathogen detection

  • Carota, Angela Gilda
  • Bonini, A|||0000-0001-9511-0699
  • Urban, Massimo|||0000-0001-6083-833X
  • Poma, Noemi
  • Vivaldi, Federico Maria
  • Tavanti, Arianna
  • Rossetti, Marianna|||0000-0001-5711-1287
  • Rosati, Giulio|||0000-0002-0227-4561
  • Merkoçi, Arben|||0000-0003-2486-8085
  • Di Francesco, Fabio|||0000-0002-9285-1595
The escalating global incidence of infectious diseases caused by pathogenic bacteria, especially in developing countries, emphasises the urgent need for rapid and portable pathogen detection devices. This study introduces a sensitive and specific electrochemical biosensing platform utilising cost-effective electrodes fabricated by inkjet-printing gold and silver nanoparticles on a plastic substrate. The biosensor exploits the CRISPR/Cas12a system for detecting a specific DNA sequence selected from the genome of the target pathogen. Upon detection, the trans-activity of Cas12a/gRNA is triggered, leading to the cleavage of rationally designed single-strand DNA reporters (linear and hairpin) labelled with methylene blue (ssDNA-MB) and bound to the electrode surface. In principle, this sensing mechanism can be adapted to any bacterium by choosing a proper guide RNA to target a specific sequence of its DNA. The biosensor's performance was assessed for two representative pathogens (a Gram-negative, Escherichia coli, and a Gram-positive, Staphylococcus aureus), and results obtained with inkjet-printed gold electrodes were compared with those obtained by commercial screen-printed gold electrodes. Our results show that the use of inkjet-printed nanostructured gold electrodes, which provide a large surface area, in combination with the use of hairpin reporters containing a poly-T loop can increase the sensitivity of the assay corresponding to a signal variation of 86%. DNA targets amplified from various clinically isolated bacteria, have been tested and demonstrate the potential of the proposed platform for point-of-need applications.